Clinical Trials Logo

Clinical Trial Summary

The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to is administered to patients with symptomatic pneumatosis cystoides intestinalis (PCI) as compared with lactomin for 8 weeks.


Clinical Trial Description

1. Based on endoscopic finding, patients with symptomatic PCI are recruited. 2. After enrollment, abdominal symptoms are evaluated and abdominal CT is performed. 3. Patients were randomized in a 1:1 ratio in blocks of 4 to undergo either the traditional Japanese medicine or lactomin (control). Randomization was carried out by computer-generated random sequences. 4. The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to(TJ-134, 7.5g/day), which consists of a mixture of a compound of peony root (6 g), cinnamon bark (4 g), jujube (4 g), glycyrrhiza (2 g), rhubarb (2 g), and ginger (1 g) or lactomin (3g/day) is administered to enrolled patients for 8 weeks. 5. After the administration of each drug for 8 weeks, abdominal symptoms are evaluated and abdominal CT is performed again. ;


Study Design


Related Conditions & MeSH terms

  • Pneumatosis Cystoides Intestinalis

NCT number NCT04368663
Study type Interventional
Source Showa Inan General Hospital
Contact
Status Recruiting
Phase N/A
Start date May 1, 2020
Completion date December 31, 2024